Molecular profiling can safely reduce radiation for women with endometrial cancer: Clinical trial results
Endometrial cancer is the most common gynecological cancer in highly-developed countries, most often affecting women after menopause. The majority of women are diagnosed at an early stage, when treatment outcomes are generally favorable.
Facebook Comments
https://www.sarkaridoctor.com/wp-content/uploads/2022/01/logo@2xx.png00aajahttps://www.sarkaridoctor.com/wp-content/uploads/2022/01/logo@2xx.pngaaja2025-05-05 12:01:592025-05-05 12:01:59Molecular profiling can safely reduce radiation for women with endometrial cancer: Clinical trial results